Aequus Pharmaceuticals Stock Analysis

Aequus OTC Stock Analysis Notes

About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Aequus Pharmaceuticals had not issued any dividends in recent years. Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Aequus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 14 people.The quote for Aequus Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Aequus Pharmaceuticals please contact Douglas Janzen at 604 336 7906 or go to https://www.aequuspharma.ca.

Aequus Pharmaceuticals Investment Alerts

Aequus Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aequus Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Aequus Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Aequus Profitablity

The company has Profit Margin (PM) of (1.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.31.

Technical Drivers

As of the 23rd of January, Aequus Pharmaceuticals shows the Mean Deviation of 5.31, risk adjusted performance of (0.01), and Standard Deviation of 13.93. Aequus Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze thirteen technical drivers for Aequus Pharmaceuticals, which can be compared to its peers. Please confirm Aequus Pharmaceuticals information ratio and skewness to decide if Aequus Pharmaceuticals is priced correctly, providing market reflects its regular price of 0.0039 per share. As Aequus Pharmaceuticals appears to be a penny stock we also recommend to validate its jensen alpha numbers.

Aequus Pharmaceuticals Price Movement Analysis

Aequus Pharmaceuticals Predictive Daily Indicators

Aequus Pharmaceuticals Forecast Models

Aequus Pharmaceuticals' time-series forecasting models are one of many Aequus Pharmaceuticals' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aequus Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Aequus Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aequus shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Aequus Pharmaceuticals. By using and applying Aequus OTC Stock analysis, traders can create a robust methodology for identifying Aequus entry and exit points for their positions.

When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.